Nature’s Sunshine Products (NATR) Set to Announce Earnings on Thursday

Nature’s Sunshine Products (NASDAQ:NATRGet Free Report) is set to announce its earnings results after the market closes on Thursday, November 7th. Nature’s Sunshine Products has set its FY 2024 guidance at EPS.Investors interested in registering for the company’s conference call can do so using this link.

Nature’s Sunshine Products (NASDAQ:NATRGet Free Report) last issued its quarterly earnings results on Thursday, August 8th. The company reported $0.07 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.25 by ($0.18). Nature’s Sunshine Products had a net margin of 3.50% and a return on equity of 9.79%. The business had revenue of $110.55 million during the quarter.

Nature’s Sunshine Products Stock Performance

Shares of NATR opened at $13.07 on Wednesday. Nature’s Sunshine Products has a 52-week low of $10.81 and a 52-week high of $21.72. The business’s 50 day moving average price is $13.32 and its two-hundred day moving average price is $14.80. The firm has a market cap of $241.90 million, a PE ratio of 16.34 and a beta of 0.87.

Analyst Ratings Changes

NATR has been the topic of a number of research reports. StockNews.com raised Nature’s Sunshine Products from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, September 10th. Canaccord Genuity Group initiated coverage on Nature’s Sunshine Products in a research report on Friday, September 13th. They set a “buy” rating and a $18.00 target price on the stock. Canaccord Genuity Group initiated coverage on Nature’s Sunshine Products in a research report on Friday, September 13th. They set a “buy” rating and a $18.00 target price on the stock. Finally, DA Davidson lowered their target price on Nature’s Sunshine Products from $23.00 to $21.00 and set a “buy” rating on the stock in a research report on Monday, August 12th.

View Our Latest Stock Report on Nature’s Sunshine Products

Insider Buying and Selling

In other Nature’s Sunshine Products news, major shareholder Fosun Pharmaceutical Shanghai sold 3,000 shares of the company’s stock in a transaction on Thursday, October 10th. The stock was sold at an average price of $13.39, for a total value of $40,170.00. Following the completion of the transaction, the insider now owns 69,347 shares in the company, valued at $928,556.33. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Over the last 90 days, insiders sold 7,499 shares of company stock worth $99,802. 4.70% of the stock is owned by corporate insiders.

Nature’s Sunshine Products Company Profile

(Get Free Report)

Nature’s Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.

See Also

Earnings History for Nature's Sunshine Products (NASDAQ:NATR)

Receive News & Ratings for Nature's Sunshine Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nature's Sunshine Products and related companies with MarketBeat.com's FREE daily email newsletter.